ArticleOral health & preventive dentistry2026
Causal Effects of Oral Microbiome, Circulating Metabolites, and Inflammatory Proteins on Recurrent Aphthous Stomatitis: A Two-Sample Mendelian Randomization Study.
Article in Oral health & preventive dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRecurrent aphthous stomatitis (RAS) affects 20% of the global population with unclear etiology and limited treatment options. While observational studies suggest associations with oral microbiome dysbiosis and metabolic alterations, causal relationships have not been established. Using Mendelian randomization, the aim of this study was threefold: 1. to systematically investigate the causal architecture underlying RAS; 2. to partition the total effect of identified microbial taxa into direct and mediator-adjusted components; 3. to determine whether specific circulating metabolites and circulating inflammatory proteins mediate the microbiome-RAS relationship. MATERIALS AND
methodsWe conducted two-sample Mendelian randomization (MR) using oral microbiome, metabolomics, inflammatory proteins, and RAS genome-wide association study summary statistics (GWAS). Univariable MR assessed direct causal effects, while multivariable MR evaluated mediation pathways. Sensitivity analyses included MR-Egger, weighted median, and MR-PRESSO.
resultsThe order Clostridiales demonstrated protective effects against RAS (OR=0.851, 95% CI: 0.759-0.954, p=0.006). Among 36 causally associated metabolites, myo-inositol (OR=1.619), sphingosine 1-phosphate (OR=1.672), and hexadecadienoate (OR=1.825) increased RAS risk, while 4-acetylphenol sulfate (OR=0.606) and acetylcarnitine (OR=0.604) conferred protection. No inflammatory proteins showed statistically significant associations. Two-step mediation analysis identified sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) as a metabolic intermediate in the Clostridiales-RAS pathway, with the direct protective effect of Clostridiales remaining statistically significant after adjustment for sphingomyelin levels.
conclusionsThis study provides genetic evidence supporting causal relationships linking the oral microbiome and metabolites to RAS, and identified Clostridiales as protective against RAS, but found multiple lipid mediators as risk factors. The interplay between Clostridiales and sphingolipid metabolism provides candidate therapeutic targets for RAS management through microbiome modulation or metabolic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.